Owen O’Connor is the Founder, Chair, and Chief Executive Officer of Nouveau Biosciences, where he has led the company’s evolution into a drug-focused biotechnology platform advancing novel nanotherapeutics for cancer. By integrating synthetic lethality screening, genomics, and computational biology, Nouveau has developed a pipeline of differentiated oncology therapies, including its lead candidate, Kromastat, which has shown […]
Since 1998, Robert Rosen has been a Managing Member of Greyhawke Capital Advisors LLC, a company which invests capital in, and applies management expertise to, selected investment opportunities generally involving net leased real estate properties. Greyhawke has also sponsored investments in multiple multi-family residential projects. Mr. Rosen was recently made a Director of Nouveau Biosciences, […]
Rich Kushel, Senior Managing Director, is the Head of the Portfolio Management Group (PMG), which encompasses BlackRock’s liquid markets, active investing across Fixed Income, Equities and Multi-Asset Strategies. He is a member of the firm’s Global Management Committee, the Global Executive Committee, and co-chair of the GEC Investment Subcommittee. Mr. Kushel’s prior roles include heading […]
Mark is a preeminent trial lawyer and employment attorney who draws on his prosecutorial background to lead cases and counsel clients on complex employment issues. His practice also encompasses conducting major internal investigations for clients and negotiating resolutions of disputes with regulatory agencies. Mark represents clients across a range of industries, including private equity, financial […]